The analgesic tramadol has minimal effect on gastrointestinal motor function

British Journal of Clinical Pharmacology

Volumn 43, Issue 1, 1997, Pages 71-75

  Wilder Smith, Clive H ^a,b   Bettiga, Andrea ^a  

^a Bean Site Hospital   (Switzerland)

^b Nociception Research Group   (Switzerland)

Author keywords

Constipation; Gastrointestinal transit; Opioids; Smooth muscle tone; Tramadol

Indexed keywords

ANALGESIC AGENT; LACTULOSE; PLACEBO; TRAMADOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR PERFORMANCE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMOOTH MUSCLE TONE; VOLUNTEER;

EID: 0031018715     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1997.tb00035.x     Document Type: Article

References (47)

1. Jaffe JH, Martin WR. Opioid analgesics and antagonists. In The pharmacological basis of therapeutics, 7th edition, ed Gilman AG, Goodman LS, Rall TW, Murad F. Basingstoke: Macmillan 1992.
2. Burks TF, Hirning LD, Galligan JJ, Davis TP. Motility effects of opioid peptides in dog intestine. Life Sci 1982; 31: 2237-2240.
3. Twycross RG, Lack SA. Symptom control in far advanced cancer: pain relief. London: Pitman Publishing Ltd; 1984.
4. Raffa RB, Friedrichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and non-opioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275-285.
5. Sevcik J, Nieber K, Driessen B, Illes B. Effects of the central analgesic tramadol and its main metabolite, O-desmethyl tramadol, on rat locus coeruleus neurones. Br J Pharmacol 1993; 110: 169-176.
6. Hennies HH, Friedrichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 1988; 38: 877-880.
7. Kayser V, Besson JM, Guilbaud G. Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in the animal model of clinical pain, the arthritic rat. Eur J Pharmacol 1992; 224: 83-88.
8. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-HT in the rat brain in vitro. Br J Pharmacol 1992; 105: 147-151.
9. Friedrichs E, Reimann W, Selve N. Contribution of both enantiomers to antinociception of the centrally acting analgesic tramadol. Naunyn-Schmiideberg's Arch of Pharmacol 1992; 346 (suppl 1): R36.
10. Wilder-Smith CH, Schimke J, Osterwalder B, Senn HJ. Oral tramadol, a μ-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain. Ann Clin Oncol 1994; 5: 141-146.
11. Raffa RB, Friedrichs E, Reimann W, Shank RP, Codd Eem Vaught JL, Jacob HL, Belve N. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993; 267: 331-340.
12. Twycross RG. Opioids. In Textbook of Pain. 3rd edition, eds Wall PD, Melzack R. New York: Churchill Livingstone; 1994: 956.
13. Budd K. Chronic pain - challenge and response. Drugs 1994; 47(suppl 1): 33-38.
14. Rauck RL, Ruoff GE, McMillan JI. Comparison of tramadol and acetaminophen with codeine for long-term pain management in elderly patients, Curr Ther Res 1994; 55: 1417-1431.
15. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 1991; 27: 7-17.
16. Vickers MD, O'Flaherty D, Szekely SM, Read M, Yoshizumi J. Tramadol: pain relief by an opioid without depression of respiration. Anesthesia 1992; 47: 291-296.
17. Houmes R-JM, Voets MA, Verkaaik A, Erdmann W, Lachmann B. Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg 1992; 74: 510-514.
18. Paravicini D, Zander J, Hansen J. Effects of tramadol on haemodynamics and blood gases in the early postoperative period. Anästhesist 1982; 31: 611-614.
19. Staritz M, Poralla T, Manns M, Meyer zum Büschenfelde KH. Effect of modern analgesic drugs (tramadol, pentazocine and buprenorphine) on the bile duct sphincter in man. Gut 1986; 27: 567-569.
20. Coelho JCU, Runkel N, Herfarth C, Senninger N, Messmer K. Effect of analgesic drugs on the electromyographic activity of the gastrointestinal tract and sphincter of Oddi and on biliary pressure. Ann Surg 1986; 204: 53-58.
21. Thompson DG, Binfield P, DeBelder A, O'Bnen J, Warren S. Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointstinal disease. Gut 1985; 26: 1349-1352.
22. 2-breath test as a measure of mouthy to caecum transit time. Gut 1983; 24: 893-896.
23. Read NW, Miles CA, Fisher D, et al. Transit of a meal through the stomach, small intestine and the colon in normal subjects and its role in the pathogenesis of diarrhea. Gastroenterology 1980; 79: 1276-1282.
24. Metcalf AM, Phillips SM, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology 1987; 92: 40-47.
25. Meier R, Beglinger C, Dederding JP, et al. Alters- und geschlechtsspezifische Normwerte der Dickdarmtransitzeit bei Gesunden. Schweiz Med Wschr 1992; 122: 940-943.
26. Sunshine A. New clinical experience with tramadol. Drugs 1994; 47(suppl 1): 8-18.
27. Stewart JJ, Weisbrodt NW, Burks TF. Central and peripheral actions of morphine on intestinal transit. J Phamacol Exp Ther 1978; 205: 547-555.
28. Ogilvy AJ, Smith G. The gastrointestinal tract after anaesthesia. Eur J Anaesthesial 1995; 10(suppl): 35-42.
29. Schiller LR. Review article: anti-diarrhoeal pharmacology and therapeutics. Aliment Pharmacol Ther 1995; 9: 87-106.
30. Coupar IM. The peristaltic reflex in the rat ileum: evidence for functional mu and delta opiate receptors. J Pharm Pharmacol 1995; 47: 643-646.
31. Culpepper-Morgan JA, Holt PR, LaRoche D, Kreek MJ. Orally administered opioid antagonists reverse both mu and kappa opioid delay of gastrointestinal transit in the guinea pig. Life Sci 1995; 56: 1187-1192.
32. Yuan CS, Foss JF, O'Connor M, Toledano A, Roizen MF, Moss J. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther 1996; 59: 469-475.
33. Thorn SE, Wattwil M, Kallander A. Effects of epidural morphine and epidural bupivacaine on gastroduodenal motility during the fasted state and after food intake. Acta Anaesthesiol Scand 1994; 38: 57-62.
34. Petring OU, Dawson PJ, Blake DW, et al. Normal postoperative gastric emptying after orthopaedic surgery with spinal anaesthesia and i.m. ketorolac as the first postoperative analgesic. Br J Anaesth 1995; 74: 257-260.
35. Ferraz AA, Cowles VE, Condon RE, et al. Nonopioid analgesics shorten the duration of postoperative ileus. Am Surg 1995; 61: 1079-1083.
36. Ashraf W, Park F, Lof J, Quigley EM. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996; 91: 26-32.
37. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985; 22: 845-858.
38. Danzebrink RM, Gebhart GF. Antinociceptive effects of intrathecal adrenorecteptor agonists in a rat model of visceral nociception. J Pharmacol Exp Ther 1990; 253: 698-705.
39. Danzebnnk RM, Gebhart GF. Evidence that spinal 5HTI, 5HT2 and 5HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat. Brain Res 1991; 538: 64-75.
40. Maves TJ, Gebhart G. Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in the rat. Anesthesiology 1992; 76: 91-99.
41. Bond JH, Levitt MD. Investigation of small bowel transit time in man utilising pulmonary hydrogen measurements. J Lab Clin Med 1975; 85: 546-552.
42. Spiller RC. Chemical detection of transit. In Illustrated guide to gastrointestinal motility. 2nd edition, eds Kumar D, Wingate D. Edinburgh: Churchill Livingstone; 1993: 308-318.
43. Welsh JD, Payne DL, Manion C, Morrison RD, Nichols MA. Interval sampling of breath hydrogen as an index of lactose malabsoprtion in lactase deficient subjects. Dig Dis Sci 1981; 26: 681-687.
44. Scarpello J. Hydrogen breath testing for lactose malabsorption. Gut 1976; 17: 245-251.
45. Caride VJ, Prokop EK, Troncale FJ, Buddoura W, Winchenbach K, McCallum RW. Scintigraphic determination of small intestinal transit time: a comparison with the hydrogen breath test. Gastroenterology 1984; 86: 714-720.
46. Van der Sijp JRM, Kamm MA. Nightingale JMD, et al. Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut 1993; 34: 402-408.
47. Wilder-Smith CH, Cariem AK, Osier W, Radebold K, Bornman P, O'Keefe SJD. The effects of tramadol and morphine on gastrointestinal transit and smooth muscle tone. Part 2: chronic pancreatitis pantients with severe pain - an interim analysis. Gastroenterology 1996; 110: A780.